These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24649548)

  • 1. [Diagnosis of melanoma].
    Maire C; Vercambre-Darras S; Desmedt E
    Rev Prat; 2014 Jan; 64(1):61-8. PubMed ID: 24649548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.
    Cadby G; Ward SV; Cole JM; Moses EK; Millward M; Palmer LJ
    Br J Dermatol; 2014 Apr; 170(4):851-7. PubMed ID: 24405011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?
    van der Rhee JI; Mooi WJ; Kukutsch NA; de Snoo FA; Bergman W
    Br J Dermatol; 2010 Feb; 162(2):457-8. PubMed ID: 19919631
    [No Abstract]   [Full Text] [Related]  

  • 4. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UV or not UV: metals are the answer.
    Meyskens FL; Berwick M
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):268-70. PubMed ID: 18268109
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma.
    Ortiz CA; Goodwin JS; Freeman JL
    Med Sci Monit; 2005 May; 11(5):RA163-172. PubMed ID: 15874907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, staging (new system), and prognosis of cutaneous melanoma.
    Cho YR; Chiang MP
    Clin Plast Surg; 2010 Jan; 37(1):47-53. PubMed ID: 19914457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous melanoma in the era of molecular profiling.
    Thompson JF; Scolyer RA; Kefford RF
    Lancet; 2009 Aug; 374(9687):362-5. PubMed ID: 19647595
    [No Abstract]   [Full Text] [Related]  

  • 9. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
    Boniol M; Armstrong BK; Doré JF
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic signs in melanoma: state of the art.
    Lomuto M; Calabrese P; Giuliani A
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):291-300. PubMed ID: 15096138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage and repair in melanoma and non-melanoma skin cancer.
    Camplejohn RS
    Cancer Surv; 1996; 26():193-206. PubMed ID: 8783574
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma.
    Moschos SJ; Konstantinopoulos PA; Kirkwood JM
    Cancer Chemother Biol Response Modif; 2005; 22():563-90. PubMed ID: 16110629
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant melanoma -- a medical students' viewpoint].
    Felcht M; Fischer JC; Michels M; Weinhold M; Zouboulis CC
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):421-30. PubMed ID: 15892844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood melanoma: what every pediatrician should know.
    Dinulos J
    Curr Opin Pediatr; 2009 Aug; 21(4):472-4. PubMed ID: 19617832
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant melanoma. Epidemiology, screening, diagnosis, evolution, prognostic clinical and histopathologic criteria].
    Roudier-Pujol C; Saiag P
    Rev Prat; 1998 Oct; 48(15):1729-35. PubMed ID: 9814078
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
    Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.